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Abstract
Background: The gp41 subunit of the HIV-1 envelope glycoprotein (Env) has been widely regarded as a type I
transmembrane protein with a single membrane-spanning domain (MSD). An alternative topology model
suggested multiple MSDs. The major discrepancy between the two models is that the cytoplasmic Kennedy
sequence in the single MSD model is assigned as the extracellular loop accessible to neutralizing antibodies in the
other model. We examined the membrane topology of the gp41 subunit in both prokaryotic and mammalian
systems. We attached topological markers to the C-termini of serially truncated gp41. In the prokaryotic system, we
utilized a green fluorescent protein (GFP) that is only active in the cytoplasm. The tag protein (HaloTag) and a
membrane-impermeable ligand specific to HaloTag was used in the mammalian system.
Results: In the absence of membrane fusion, both the prokaryotic and mammalian systems (293FT cells) supported
the single MSD model. In the presence of membrane fusion in mammalian cells (293CD4 cells), the data obtained
seem to support the multiple MSD model. However, the region predicted to be a potential MSD is the highly
hydrophilic Kennedy sequence and is least likely to become a MSD based on several algorithms. Further analysis
revealed the induction of membrane permeability during membrane fusion, allowing the membrane-impermeable
ligand and antibodies to cross the membrane. Therefore, we cannot completely rule out the possible artifacts.
Addition of membrane fusion inhibitors or alterations of the MSD sequence decreased the induction of membrane
permeability.
Conclusions: It is likely that a single MSD model for HIV-1 gp41 holds true even in the presence of membrane
fusion. The degree of the augmentation of membrane permeability we observed was dependent on the
membrane fusion and sequence of the MSD.
Background
The envelope glycoprotein (Env) of human immunodefi-
ciency virus type-1 (HIV-1) plays a critical role in the
early stage of HIV-1 infection. Env is synthesized as a
precursor protein, gp160 [1,2], and processed into gp120
and gp41 during transport from the endoplasmic reticu-
lum to Golgi network [3,4]. The gp120 subunit deter-
mines host range through its recognition of the receptor
and co-receptor complex. The transmembrane protein
gp41 mediates the membrane fusion between the host
and viral membranes. It is composed of an ectodomain
(extracellular domain), a cytoplasmic domain, and a
transmembrane domain. The ectodomain has coiled-
coil-forming heptad repeats essential for membrane
fusion. The cytoplasmic domain contains three amphi-
pathic helices called the lentiviral lytic peptide (LLP) 1,
2 and 3. The LLP-1 and LLP-2 portions have a high
hydrophobic moment common to membrane-lytic pep-
tides [5-9].
The transmembrane domain of gp41 was first deduced
from the hydropathy plot of Env as a hydrophobic
domain [10]. This transmembrane domain, herein
referred to as the membrane-spanning domain (MSD),
is composed of 23 highly conserved amino acid residues
corresponding to amino acid residues 684 to 706 in the
HXB2 strain (Figure 1A, B). An in vitro translation
study in the presence of microsomal membranes sug-
gested that HIV-1 Env has one MSD [11], as predicted
by the hydropathy plot. In that study, the C-terminus of
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membrane [11], hence the gp41 subunit is regarded as a
type I membrane protein with a single MSD. Other stu-
dies provided data consistent with this single MSD
model. For example, two cysteine residues for palmitoy-
lation are located in the cytoplasmic domain: one in the
middle of LLP-1 (Cys-838) and the other at the
upstream of LLP-2 (Cys-765) [12]. The internalization
motif, YXXL (Tyr-769 to Leu-772), at the beginning of
LLP-2 [13] also maps to the cytoplasmic domain of the
single MSD model.
On the other hand, the mapping of the epitopes for
neutralizing antibodies called into question the single
MSD model. Some of the epitopes were mapped to the
cytoplasmic region which contained the amino acid
sequence known as the Kennedy sequence (
724PRGPD
RPEGIEEEGGERDRDRS
745)[14-16] (Figure 1A).
Furthermore, a report using an antibody raised against
the LLP-2 portion revealed target binding during mem-
brane fusion when added extracellularly [17]. As antibo-
dies in general are not expected to cross intact
membranes, an alternative membrane topology model of
gp41 has been suggested in order to assign the mapped
epitopes in the extracellular region [16] (Figure 1C). In
this alternative model multiple MSDs were proposed
because the C-terminus was assumed to be in the cyto-
plasm. Furthermore, the transmembrane portion of the
single MSD model is expected to cross the membrane
twice and one of LLPs, LLP2, is a putative third MSD
(Figure 1C).
Several studies of the transmembrane portion of the
single MSD model showed that it plays a critical role in
the modulation of the membrane fusion process, which
is an essential step of the HIV-1 life cycle [18-24].
Therefore analysis of the topology and structures of the
transmembrane domain of gp41 is critical for our
understanding of the mechanism of the membrane
fusion. Furthermore the location of the neutralizing epi-
topes for antibodies is vital for a vaccine development.
In this study we reexamined gp41 topology in two dif-
ferent biological systems; prokaryotic and mammalian
systems. The results of prokaryotic and mammalian sys-
tems without membrane fusion supported the single
MSD model. The results obtained in the mammalian
system in the presence of membrane fusion seem to
support a transient alteration of the membrane topology
of gp41. It is important, however, to note that the effect
of the induction of membrane permeability during HIV-
1 Env-mediated membrane fusion cannot be excluded.
The induction of membrane permeability was reduced
by replacing the HIV-1 MSD with that of a foreign pro-
tein, CD22.
Methods
Plasmid construction
All PCR amplicons were first cloned into pCR4Blunt-
TOPO using the TOPO cloning kit (Invitrogen, Carls-
bad, CA) and sequences were verified.
For the topology analysis in the prokaryotic system,
the expression vector pKMal-p2e was generated.
pKMal-p2e has a kanamycin resistance gene derived
from pK18 instead of b-lactamase in the context of
pMal-p2e (NEB, Beverly, MA). The oligonucleotide
adaptor generated by annealing the following two oligo-
nucleotides: 5’-GTACCG AACAAT TACAC
AAGCTTC GGATC CTCTAGA GTCGAC CTGCAG
GC G-3’ and 5’-AGCTC GC CTGCAG GTCGAC
TCTAGA GGATCC GAAGCT TGTGTA ATTGTT
CG -3’ were inserted into pKMal-p2e to modify the
multiple cloning site. This modified vector was named
as mpKMal-p2e. The green fluorescent protein (GFP)
gene as the reporter for the membrane topology was
prepared by PCR using GFPopt1-11 in pCR4Blunt-TOPO
[25] as the template with 5’-GAC TCTAGA ATGGTG
AGCAAG GGCGAG GAGC-3’ and 5’-GCACTG
CAGTCA GGTGAT GCCGGC GGCGT-3’ as the for-
ward and reverse primer, respectively, and cloned into
mpKMal-p2e vector using XbaIa n dPstI sites. The gen-
erated vector was named as mpKMalp2e-GFP (Table 1).
Figure 1 Schematic representation of Env mutants used in this
study and the proposed topology models. (A) The points of
truncation of gp41 were indicated together with a schematic
diagram of the gp41 subunit. ED: ectodomain, MSD: membrane-
spanning domain, CT: cytoplasmic tail, LLP: lentiviral lytic peptide.
The numbering of the amino acid is based on that of the HXB2
strain. The vertical dashed line shows the position of the N-terminus
of the gp41 used for the analysis in the bacterial system. The
numbers and letters on the right indicate the position and the
amino acid residue of the C-terminus. (B and C) Proposed topology
models. The grey numbered arrowheads indicate the truncation
points of gp41, the numbers and colors correspond to (A).
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experiment.
The near full-length gp41 gene derived from the
HIV-1 HXB2 strain was amplified by PCR using
pGEM7zf(+)-NB [23] as a template with 535fACC651
(Met):5’-AGTGGT ACCGAT GACGCT GACGGT
ACAGGC CAGA-3’ and 856 rXbaI: 5’-GTCTCT AGA-
TAG CAAAAT CCTTTC CAAGCC CTG-3’ as the for-
ward and the reverse primer, respectively. The plasmid
that harbors near full-length gp41 in pCR4blunt-TOPO
was named as pEnv-HXb2gp41. For the construction of
the gp41 mutants, the C-termini were serially truncated,
(see Table 1 and Figure 1A), the various gp41 fragments
were amplified by PCR using pEnv-HXb2gp41 as a tem-
plate, with the oligonucleotide 535fACC651 as a forward
primer, and the corresponding reverse primer designed
for each truncation site. These truncated gp41 fragments
were cloned into the vector mpKMalp2e-GFP with Hin-
dIII, which is present in the gp41 gene, and XbaIa tt h e
5’ and 3’ terminus, respectively of the fragments. Figure
2A shows the resulting mpKMalp2e-gp41-GFP fusion
constructs. The plasmid, optGFP1-11/pET-47md [26]
Table 1 Plasmids used in this study
Plasmids Description
For prokaryotic system
mpKMalp2e-GFP Multiple cloning site-modified pMalp2e containing Kan
R and Green fluorescent protein genes
mpKMalp2e-gp41-1-GFP mpKMalp2e-GFP with C-terminally truncated gp41 at W666
mpKMalp2e-gp41-2-GFP mpKMalp2e-GFP with C-terminally truncated gp41 at I682
mpKMalp2e-gp41-3-GFP mpKMalp2e-GFP with C-terminally truncated gp41 at G694
mpKMalp2e-gp41-4-GFP mpKMalp2e-GFP with C-terminally truncated gp41 at R725
mpKMalp2e-gp41-5-GFP mpKMalp2e-GFP with C-terminally truncated gp41 at R747
mpKMalp2e-gp41-6-GFP mpKMalp2e-GFP with C-terminally truncated gp41 at R788
mpKMalp2e-gp41-7-GFP mpKMalp2e-GFP with C-terminally truncated gp41 at A819
mpKMalp2e-gp41-8-GFP mpKMalp2e-GFP with full-length gp41
optGFP1-11/pET-47md Modified pET-47b with modified super folder GFP
For mammalian system
pHIVenv-Halo The CMV promoter driven mammalian expression vector containing HaloTag gene
pHIVenv-gp41-4-Halo pHIVenv-Halo containing Env with C-terminally truncated gp41 at R725
pHIVenv-gp41-5-Halo pHIVenv-Halo containing Env with C-terminally truncated gp41 at R747
pHIVenv-gp41-6-Halo pHIVenv-Halo containing Env with C-terminally truncated gp41 at R788
pHIVenv-gp41-7-Halo pHIVenv-Halo containing Env with C-terminally truncated gp41 at A819
pHIVenv-gp41-8-Halo pHIVenv-Halo containing full-length Env
pHIVenv-gp41-5 Halo-deleted pHIVenv-gp41-5-Halo
pHIVenv-gp41-8 Halo-deleted pHIVenv-gp41-8-Halo
pHIVenv-CD22-gp41-5 The gp41 MSD replaced pHIVenv-gp41-5 with the MSD of CD22
pHIVenv-CD22-gp41-8 The gp41 MSD replaced pHIVenv-gp41-8 with the MSD of CD22
pHook-Halo-GPI The expression vector of the GPI anchored-HaloTag
pKcTac-Halo The expression vector of Tac antigen of IL-2 receptor fused with C-terminal HaloTag
pKcTac-FLAG pKcTacHalo vector whose HaloTag was replaced with 3xFLAG
Figure 2 Constructs used to express recombinant gp41 in the
E. coli system. (A) The expression vectors used in this study. The
env gene is derived from HIV-1 HXB2 strain. gp41 starts amino acid
636 and ends with the various C-terminal positions as indicated in
Fig. 1A. The schema below the plasmid map shows the
components of the recombinant proteins. The truncated gp41 is
preceded by maltose binding protein (MBP) and followed by the
topological reporter, green fluorescent protein (GFP). The
nomenclatures are as follows: lacI, lacI repressor gene; pTac, a hybrid
promoter between trp and lac promoters; CT, cytoplasmic tail;
AmpR, ampicilin resistant gene; f1ori, replication origin of f1;
pER322ori, replication origin of pBR322 plasmid. (B) Expression of
the recombinant proteins. The immunoblotting of bacterial lysates
probed with the anti-GFP antibody is shown. The name on the top
of each lane indicates the expression vector used (see Table 1).
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tive control.
The Halo7 gene was amplified by PCR using pFC14k-
HaloTag7 (Promega, Madison, WI) as a template, with
5’- GTCGAC GGCGGT GGCGGT AGCGGA TCCGAA
ATCGGT ACTG-3’ and 5’- GGTACC TTAACC
GGAAAT CTCCAG AG -3’ oligonucleotides as the for-
ward and the reverse primer, respectively. The forward
primer contained a SalI site and short linker sequence,
Gly4Ser, between the SalI site and Halo7 coding region.
The reverse primer included an Acc65I site. The ampli-
con was inserted into the pHIVenvOPT vector, contain-
ing an envelope gene based on HXB2 strain that was
optimized for human codon usage. The vector generated
was named as pHIVenv-Halo (Figure 3A). To construct
the truncation gp41 mutants for the mammalian ana-
lyses, five different positions were chosen as the
C-terminal truncation points (Figure 1A and Table 1).
The fragments of truncated env from XmnIt oe a c ht e r -
mination codon were amplified by PCR using pHIVen-
vOPT as a template with 5’-GCTAGC AAATTA
AGAGAAC-3’ including the SalI site as the forward pri-
mer and the corresponding oligonucleotides at the trun-
cated sites as the reverse primers, respectively. The env
fragments were inserted into pHIVenv-Halo (Table 1).
For the construction of pHIVenv-gp41-5 and pHIVenv-
gp41-8, stop codon-containing oligonucleotides gener-
ated by annealing 5’-TCGACTGATGAG -3’ with 5’-
GTACCTCATCAG-3’ was replaced with HaloTag gene
to delete HaloTag. The Env expression vector with the
MSD of CD22 [27] was constructed using PCR and repla-
cement of the original MSD with the MSD of CD22. As
for the control plasmids, two other expression vectors
were constructed. The glycosylphosphatidylinositol
(GPI)-anchored HaloTag gene was constructed as a mar-
ker for surface expression of HaloTag (Halo-GPI in Fig-
u r e3 Aa n dT a b l e1 ) .T h eG P Is i g n a li sd e r i v e df r o m
decay accelerating factor of human origin [28]. A Tac
antigen, which is alpha subunit of Interleukin-2 receptor
and is a single transmembrane protein [29], was fused
with HaloTag gene at the C-terminus (Tac-Halo in Fig-
ure 3A and Table 1). This construct was used for the
expression of the HaloTag protein in the cytoplasm. A
derivative of this expression vector for Tac with a FLAG
epitope at its C-terminus (Tac-FLAG) was generated by
r e p l a c i n gt h eH a l o T a gs e q u e n c ew i t ht h a tf o r3 x F L A G
tag.
Expression of GFP-fused gp41 proteins and measurement
of GFP fluorescence intensity
E. coli strain BL21 transformed with mpKMal-p2e carry-
ing serially truncated gp41 genes fused to GFP reporter
was grown overnight at 22°C in TAG medium (10 g/L
Tryptone, 5 g/L NaCl, 5 g/L Glucose, 7 g/L K2HPO4,3g /
LK H 2PO4,1g / L( N H 4)2SO4, 0.47 g/L Sodium Citrate)
with 50 μg/ml kanamycin. The overnight bacterial cul-
ture was diluted 1:50 in 4 ml TAG fresh medium con-
taining 50 μg/ml kanamycin and growth was continued
at 22°C until the OD600 reached 0.2. Cells were grown for
overnight in the presence of 0.1 mM IPTG. Subsequently,
one ml aliquot of culture was collected and resuspended
in 0.5 ml of PBS buffer and the GFP fluorescence inten-
sity was measured by flow cytometry using a FACS Cali-
bur (BD Biosciences, Mississauga, ON). At the same
time, another 1 ml aliquot of culture was dispensed for
SDS-PAGE and immunoblotting analysis.
Mammalian cell culture, transfection, labeling, and
imaging
The 293FT cells (Invitrogen, Carlsbad, USA) or 293CD4
cells (293 cells constitutively expressing human CD4) [23]
Figure 3 Constructs used for the expression of reporter
proteins in the mammalian system. (A) The expression vector
used in this study. The env gene of HXB2 origin was codon-
optimized for human genes. The nomenclatures are as follows:
pCMV, cytomegalovirus promoter; CT, cytoplasmic tail; HaloTag,
Halo7 gene; f1ori, replication origin of f1; Kan/NeoR, kanamycin or
neomycin resistant gene; pER322ori, replication origin of pBR322
plasmid. The composition of the fusion protein used in the study
was indicated below the plasmid map. The gp41 proteins with
different C-terminal truncation points were fused to HaloTag at their
C-terminus. The Halo-GPI, and Tac-Halo constructs and their
expected membrane topology are shown schematically. (B) The
result of immunoblotting with anti-HaloTag antibody. The names of
the mammalian expression vector used are indicated above each
lane. (C) Analysis of membrane fusion efficiency. The fusion activity
of Halo-fused Env was evaluated by the syncytia-forming activity in
293CD4 cells. The percentage of the number of the nuclei included
in syncytia was calculated by counting 300 nuclei in total. The
constructs tested are indicated at the bottom of each bar; the
number indicated the truncation points shown in Fig.1A.
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away, NJ) with Dulbecco’s modified Eagle medium
(DMEM; Sigma, St. Louis, USA) supplemented with 10%
FBS (Hyclone Labs., Logan, UT). In the case of 293FT,
5 μg/ml Geneticine (GiBco, Grand Island, USA) was further
supplied. Cells were grown at 37°C in 5% CO2 incubator.
DNA transfection of mammalian cells was performed
using Fugene HD (Roche, Indianapolis, USA; Fugene
HD (μl): DNA(μg): DMEM(μl) = 5:2:200). The transfec-
tion mix was incubated for 15 mins at room tempera-
ture prior to addition to the cell culture in a drop-wise
manner (10 μl per well). After certain hours of transfec-
tion the transfected cells were subjected for further ana-
lyses as described below.
At the indicated time after transfection, the transfected
cells were probed with HaloTag ligands. The starting
time point of labeling after transfection was different for
different experiments involving a different set of cells and
vectors (see the Results section). The labeling was per-
formed as suggested by the manufacturer (Promega).
Briefly, the transfected live cells were labeled for 15 mins
at 37°C with 1 μM of HaloTag ligand Alexa Fluor 488
(AF488), a membrane-impermeable ligand, or Oregon
Green (OG), a membrane permeable ligand, respectively.
After labeling, the cells were rinsed three times with 200
μl prewarmed DMEM plus 10% FBS and subsequently
incubated at 37°C with 5% CO2 for 30 mins. The medium
was changed with fresh warm DMEM plus 10% FBS, then
images were captured using a confocal microscope
(Olympus FluoView FV1000, Tokyo, Japan).
Immunofluorescent staining assay using the anti-FLAG
monoclonal antibody (Sigma) was performed to detect
the FLAG-tagged proteins as below. Following the fixa-
tion of the transfected cells with 2% paraformaldehyde at
25°C for 5 mins, the anti-FLAG antibody (1/200 in 0.5%
BSA and PBS) was used as the first antibody. After incu-
bating at room temperature for 1 h, the cells were rinsed
3 times with 200 μl prewarmed PBS plus 0.5% BSA and
subsequently incubated with anti-mouse antibody conju-
gated with AlexaFluor 488 (Invitrogen) (1/200 in 0.5%
BSA and PBS) at room temperature for 1 h. The images
were captured using a confocal microscope (Olympus).
To evaluate the cell viability, staining with propidium
iodide (PI) [30] was used. In the case of co-labeling with
the HaloTag ligands, staining with AF488 was per-
formed first, then PI staining for 15 min at room tem-
perature with a final concentration of 2.5μg/ml followed.
The cells were rinsed two times with PBS and images
were analyzed as described above. In the case of co-
staining with anti-FLAG monoclonal antibodies, PI
staining was performed first, followed by labeling with
the anti-FLAG monoclonal antibody.
To mimic the effect of the conformational changes of
gp120 after its binding to the CD4 receptor, soluble
CD4 was added to the 293FT cells transfected with
HIV-1 Env expression vectors. The soluble CD4 protein
(final concentration: 0.1 μM) was kept in the medium
since immediately after transfection.
Syncytia formation assay
A syncytia formation assay was performed by transfect-
ing the HIV-1 Env expression vectors (listed as For
mammalian system in Table 1) into the 293CD4 cells.
The cells were transfectedw h e nt h e yw e r ea b o u t5 0 %
confluent. At 48 h after transfection, the images were
captured with IN Cell analyzer 1000 (GE Healthcare,
Uppsala, Sweden). The fusion activity of Halo-fused Env
was evaluated by counting 300 nuclei in total after stain-
ing with 2 μM Hoechst and determining the percentage
of nuclei included in syncytia.
Immunoblot analysis
Bacterial cultures (1 ml) were harvested and resus-
pended in 50 μl SDS-PAGE loading buffer (2% SDS, 2
mM DTT, 10% glycerol, 50 mM Tris-HCl, pH6.8, 0.01%
Bromo phenol blue). The mixture was kept for 10 mins
at 95°C and subjected to centrifugation (20,000 g, 4°C)
with MX-301 (Tomy, Japan) to remove the pellets.
Whole cell lysates (2 μl) were resolved using a 5-20%
gradient SDS polyacrylamide gel (DRC, Tokyo, Japan).
The proteins were transferred to the PVDF membrane
and probed with 15,000-fold diluted anti-GFP antibody
(Santa Cruz Biotechnology, Santa Cruz, USA) for 1 h at
room temperature. Anti-mouse antibody (GE health-
care), diluted by 5,000-fold, was used as the secondary
antibody. The signal was developed by streptavidin-
biotinylated horseradish peroxidase complex (GE health-
care) and the chemiluminescence reagents (Roche), and
detected by LAS3000 (Fuji).
The transfected 293FT cells grown in 10-cm dishes as
described above were collected and centrifugated (5,000
g, 4°C) with MX-301. The cell pellet was lysed with
250μl of RIPA lysis buffer [50 mM Tris-Cl (pH 7.4), 150
m MN a C l ,1 %N P - 4 0 ,0 . 1 %S D S ]a n dt h e nc e n t r i f u g e d
(MLA-130 rotor, 100,000rpm, 30 mins, 4°C) with Beck-
man Optima™Max Ultracentrifuge. The supernatant (20
μl) was treated with the same method as described
above. The protein bands on the PVDF membrane were
developed as described above, except for the 500-fold
diluted anti-Halo pAb (Promega) and 5000-fold diluted
anti-rabbit antibody (GE healthcare) which were used as
the primary and secondary antibodies, respectively.
Results
Topology mapping of gp41 using GFP as a reporter in a
prokaryotic system
We first employed the well-established prokaryotic
topological analysis using GFP as a reporter [31,32]. If
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form, whereas when it is translocated into the periplasm
it is non-functional [31]. The periplasm-targeted mal-
tose-binding protein was placed at the N-terminus of
the gp41 portion to be tested, and then GFP, a topologi-
cal reporter, was fused to the C-terminus of the gp41
fragment (Figure 2A). The series of gp41 proteins trun-
cated at the different C-terminal positions were tested
(Figure 1A and Table 1). The N-terminus of gp41 por-
tion included was fixed at the position of 636th amino
acid close to the predicted MSD (Figure 1A dotted line),
because there is little controversy on the beginning of
the MSD itself.
After transformation of E. coli.w i t ho n eo ft h ep l a s -
mids, the expression of the recombinant protein was
evaluated by immunoblotting using an anti-GFP anti-
body and the results are shown in Figure 2B. The levels
of protein expression with mpKMalp2e-gp41-1-GFP,
mpKMalp2e-gp41-2-GFP, and mpKMalp2e-gp41-3-GFP,
were low (Figure 2B), and we did not analyze these
constructs further. The rest of constructs each expressed
a comparable amount of the fusion protein of about
100kD (Figure 2B). The fluorescence intensities of GFP
at 530 nm of E. coli induced for the expression of the
fusion proteins were measured by a flow cytometry.
Compared with the negative control that expresses GFP
in the periplasm (mpKmalp2e-GFP), the GFP intensity
adjusted by the cell density was significantly higher for
mpKMalp2e-gp41-4-GFP, mpKMalp2e-gp41-5-GFP,
mpKMalp2e-gp41-6-GFP mpKMalp2e-gp41-7-GFP and
mpKMalp2e-gp41-8-GFP (Table 2). This suggested that
GFP attached at the position 4 to 8 lies in the cyto-
plasm. Interestingly, there was no significantd i f f e r e n c e
in the GFP fluorescent intensity adjusted by the level of
the expression for mpKMalp2e-gp41-4-GFP,
mpKMalp2e-gp41-5-GFP, mpKMalp2e-gp41-6-GFP,
mpKMalp2e-gp41-7-GFP and mpKMalp2e-gp41-8-GFP.
These data suggested that there was no topological shift
of GFP reporter in these regions; therefore the Kennedy
sequence and LLP regions are not exposed to the
periplasmic region. These results are consistent with the
single MSD model of gp41 (Figure 1B).
Expression of HaloTag-attached HIV-1 Env in mammalian
cells
Although the bacterial system is quick and informative,
eukaryote specific post-translational modifications and/
or the difference in the composition of lipids in the
membrane may affect the topology of gp41. Therefore,
HIV-1 Env with the C-terminus of gp41 linked to Halo-
Tag was expressed in mammalian cells (Figure 3A). The
HaloTag is a 33 kDa protein designed to covalently bind
to its membrane-permeable/impermeable ligands conju-
gated with a fluorescent chromophore [33]. Based on
the previous published results [11] and our own results
of the prokaryotic system (see above), we focused on the
analysis of the region after the predicted MSD of the
single MSD model (truncation positions 4-8 in Figure
1A). The GPI-anchored HaloTag protein (Halo-GPI)
and the HaloTag attached to the C-terminus of the Tac
antigen after MSD (Tac-Halo) were made as the con-
trols for the extracellular and intracellular positioning of
HaloTags, respectively (Figure 3A and Table 1). Expres-
sion of HaloTag-attached envelope proteins was con-
firmed by immunofluorescence analysis with anti-gp120
antibody (data not shown) and immunoblotting analysis
with anti-Halo antibodies (Figure 3B). The bands around
130-170kD and 40-55kD for pHIVenv-gp41-Halo are
HaloTag-attached gp160 and gp41, respectively.
The membrane fusion capacity of these mutants was
examined with a syncytia formation assay by transfecting
the expression vector into 293CD4 cells [23]. Although
the efficiency of the fusion was reduced in all of the
HaloTag-attached envelope proteins, all still retained
membrane fusion activity (Figure 3C). When we ana-
lyzed the fusion activity with the DSP assay [34], better
fusion was observed (data not shown). Since the DSP
assay relies on the smaller reporter proteins, the pre-
sence of the defect of pore dilatation in HaloTag
attached mutants was suggested.
Topology mapping of gp41 in mammalian cells using
HaloTag-specific membrane-impermeable ligands
The membrane-permeable and membrane-imperme-
able ligands with fluorescent chromophore available
for HaloTag were used to examine the location of the
attached HaloTag in relation to the cell membrane.
Oregon Green (OG) that readily cross the cell mem-
brane labels HaloTag located in both extracellular and
intracellular spaces, whereas Alexa Fluor 488 (AF488),
a membrane-impermeable ligand, should label Halo-
Tag exposed on the cell surface. When we used the
membrane-permeable substrate, OG, all of the 293FT
cells transfected with HaloTag-fused truncated Env
Table 2 Results of GFP quantification
Vector Adjusted GFP signal
(The number of counts
/OD600)
optGFP1-11/pET-47md 4026.238
mpKMalp2e-gp41-4-GFP 1103.775
mpKMalp2e-gp41-5-GFP 971.453
mpKMalp2e-gp41-6-GFP 828.177
mpKMalp2e-gp41-7-GFP 1018.790
mpKMalp2e-gp41-8-GFP 986.997
mpKmalp2e-GFP 313.958
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Halo, pHIVenv-gp41-6-Halo, pHIVenv-gp41-7-Halo,
and pHIVenv-gp41-8-Halo) were stained by the ligand
(Additional File 1; Figure S1). The 293FT cells trans-
fected with pHook-Halo-GPI and pKcTac-Halo were
also stained by OG; the fluorescent signal was loca-
lized at the rim of the cells (Additional File 1; Figure
S1). On the other hand, when we used the membrane-
impermeable substrate, AF488, none of the 293FT
cells transfected with the plasmids harboring Halo-
Tag-fused Env with C-terminal truncation were
stained (Figure 4 pHIVenv-gp41-4 to -8-Halo). As
expected, the 293FT cells transfected with pHook-
Halo-GPI were stained by AF488, but the 293FT cells
transfected with pKcTac-Halo did not show any fluor-
escent signal under the same labeling and imaging
conditions (Figure 4), verifying the authenticity of this
experimental system. These results indicate that the
HaloTag attached at positions 4 to 8 of gp41 are
located in the cytoplasm of the cells. This result is
consistent with the prokaryotic data (Table 2) and
suggests that Kennedy sequence and LLP regions are
both located in the cytoplasm, supporting the single
MSD model of gp41 [11].
Figure 4 Topological analysis of gp41 in 293FT cells. Images of the cells stained with the membrane impermeable ligand, Alexa Fluor 488
(AF488), for HaloTag. The staining and image capturing were done at 44 h post transfection. Mock, mock DNA transfection. The names of
expression vectors are shown. The bar indicates 30 μm.
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Page 7 of 14Examination of membrane topology with HaloTag in
syncytia formed in 293CD4
As the possibility for a transient topological change of
gp41 during membrane fusion has been proposed
[16,17], we induced the formation of syncytia in
293CD4 by transfecting a series of Env-HaloTag expres-
sion vectors and performed the labeling. All of the syn-
cytia formed after transfecting the expression vector for
each Env-HaloTag were positively stained with OG,
membrane-permeable ligand, during membrane fusion,
confirming the expression of Halo-fused Envs (Addi-
tional File 2; Figure S2). When the membrane-imperme-
able ligand AF488 was used for staining, most of the
multinucleated 293CD4 cells expressing various gp41
truncation mutants were not stained (Figure 5). The
only exception was the cells transfected with pHIVenv-
gp41-5-Halo, in which rare and weak staining of the
syncytia were observed (Figure 5). Even the later time
points with the similar levels of syncytia formation with
pHIVenv-gp41-8-Halo were chosen to compensate the
reduced fusion efficiency of pHIVenv-gp41-5-Halo, the
staining incidence for pHIVenv-gp41-5-Halo did not
increase. The 293CD4 cells transfected with the control
plasmids, pHook-Halo-GPI (HaloTag on the cell sur-
face) and pKcTac-Halo (HaloTag in the cytoplasm),
showed the results consistent with their expected topo-
logical locations (Figure5p H o o k - H a l o - G P Ia n d
pKcTac-Halo).
Figure 5 Topological analysis of gp41 in 293CD4 cells. Images of the cells stained with membrane impermeable ligand, Alexa Fluor 488
(AF488). The staining and image capturing were done at 20 h post transfection. The abbreviations used are same as in Fig. 4. The bar indicates
30 μm.
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Page 8 of 14When the 293CD4 cells transfected with pHIVenv-gp41-
5-Halo were stained with the anti-HaloTag antibody
without permeabilization procedure, rare events of stain-
ing were observed (data not shown). These results sug-
gest that the possibility of sporadic exposure of
cytoplasmic domain of gp41 during membrane fusion
with pHIVenv-gp41-5-Halo.
Augmented membrane permeability by Env-induced
membrane fusion
The result shown above for pHIVenv-gp41-5-Halo could
be an indication of a rare translocation of the cytoplas-
mic region of the gp41. The reason why the transloca-
tion, if happening, is limited to the truncation at
position 5 with a very low incidence was not clear.
Since there was no staining for pHIVenv-gp41-4-Halo,
we have to assume a hypothetical MSD between the
position 4 and 5. This is to assume the Kennedy region
to be the hypothetical MSD and is different from the
model shown in Figure 1C. The hydrophilic Kennedy
sequence is not likely to be an MSD by several predic-
tion algorithms (Table 3). An alternative possibility is
that the sporadic staining was due to the induced per-
meability of membranes in syncytia.
To distinguish the alteration of gp41 topology from
membrane permeability induced during membrane
fusion, we co-expressed tag-free HIV-1 Env together
with Tac-Halo in the same cells. Namely, the pKcTac-
Halo, and pHIVenv-gp41-5/pHIVenv-gp41-8 or pHI-
Venv-CD22-gp41-5/pHIVenv-CD22-gp41-8 (Table 1)
were co-transfected simultaneously. We then probed the
HaloTag expressed in the cytoplasmic side (see Figure
3A) with AF488, membrane-impermeable ligands. Both
293FT (fusion incompetent) and 293CD4 (fusion com-
petent) cells were used to determine the effect of mem-
brane fusion. The co-transfected 293FT cells were not
stained with AF488 (Figure 6 -soluble CD4), whereas
these cells were stained with OG (data not shown). The
expressions of Env in 293FT cells were confirmed by
immunoblotting (Additional file 3; Figure S3). The addi-
tion of soluble CD4, which can induce the early confor-
mational change of gp120, did not show any changes in
the staining patterns (Figure 6 + soluble CD4).
In the case of 293CD4 cells, however, the co-trans-
fected cells (Figure 7 -C34, pHIVenv-gp41-5 or 8 +
pKcTac-Halo,) could be clearly stained by AF488 at the
site of syncytium (Figure 7 -C34). These staining were
not due to the cell death, because some cells labeled
with AF488 did not show the staining with propidium
iodide (Figure 7 shown in red). The staining with AF488
was abolished when membrane fusion was inhibited by
the addition of C34, an inhibitor of six-helix bundle for-
mation (Figure 7 +C34, pHIVenv-gp41-5 or -8
+pKcTac-Halo). These results indicated that the induc-
tion of the permeability was dependent on active mem-
brane fusion.
To examine whether the observed membrane perme-
ability during membrane fusion allows antibodies to
penetrate membranes, we probed the 3 × FLAG epitope
attached to the cytoplasmic portion of the Tac antigen
(Tac-FLAG) with the anti-FLAG antibody. The intracel-
lular 3 × FLAG tag was detectable when HIV-1 Env
with or without the truncation, pHIVenv-gp41-5 and
pHIVenv-gp41-8, respectively, were co-expressed (Figure
8 -C34). Although the staining pattern of each syncy-
tium varies, it seemed that the incidence of the posi-
tively stained syncytia was slightly lower than that
obtained with the membrane-impermeable ligands
shown in Figure 7. When the membrane was permeabi-
lized with detergent prior to antibody staining, all of
syncytia were stained well (data not shown). These
results suggest both the full-length and truncated Env
have the ability to permeabilize the membrane to allow
the antibodies to cross the membranes.
Augmented membrane permeability is dependent on
MSD sequence
Since membrane permeability was induced in the cells
transfected with pHIVenv-gp41-5-Halo, the presence of
LLPs is not required for the increased permeability. To
further characterize the region required for this enhanced
permeability we constructed the mutants in which the origi-
nal gp41 MSD was replaced with the foreign MSD derived
from CD22 [27] in the pHIVenv context. Previous reports
indicated that the MSD derived from CD22 did not alter
the function of HIV-1 Env [27]; however, the replacement
seemed to delay the appearance of syncytia when compared
with the wild type (see below). We compared these mutants
with the HIV-1 Env with the native MSD. In the case of the
HIV-1 Env with its native MSD, intracellular HaloTag was
detectable with membrane-impermeable AF488 at the ear-
lier time point after co-transfection (16 h post transfection,
Figure 7; pHIVenv- gp41-5 and 8). On the other hand,
there was minimal staining in cells co-transfected with
HIV-1 Env with CD22 MSD at 16 h after transfection (data
not shown). At 44 h post transfection when the cells trans-
fected with the native gp41 MSD were almost gone due to
Table 3 Computational analyses of possible
transmembrane domain
Program Region of the predicted membrane-spanning segment
(original: 684-706)
TroPred 684-705
TMHMM 678-701
SOSUI_MP1 675-708
SOSUI 683-706
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Page 9 of 14the cell death, some cells transfected with CD22 MSD
mutants were stainable with AF488 (Figure 7 -C34, pHI-
Venv-CD22-gp41-5 or 8 + pKcTac-Halo). Therefore there
is a significant difference in the pattern of the staining
between the native and CD22 MSDs. At 44 h post transfec-
tion, there were more dead cells as indicated by the positive
PI staining. These cells were also stained with AF488.
There are, however, some syncytia stained only with AF488
for CD22 MSD mutants (Figure 7). Inhibition of the mem-
brane fusion with C34 blocked the staining (Figure 7
+C34). Similar results were obtained if anti-FLAG antibo-
dies were used to detect the FLAG tag located in the cyto-
plasm. (Figure 8 pHIVenv-CD22-gp41-5 or 8 + pKcTac-
FLAG). Taken together, these results indicated that the
induction of permeability was membrane fusion-dependent
and that the gp41 MSD played some role in the degree of
induced permeabilization during membrane fusion.
Discussion
In this study we examined the membrane topology of
the gp41 subunit in two different biological systems.
The truncated gp41 subunit was tagged with the topolo-
gical reporter protein at the C-terminus (Figure 1, 2, 3).
A prokaryotic reporter, GFP [31,32] and mammalian
reporter, HaloTag [33], were used. Both reporters
enabled us to examine the topology in living cells with-
out the artifacts caused by fixing.
In our prokaryotic system, all of the tested constructs
(mpKMalp2e-gp41-4, 5, 6, 7- and 8-GFP) showed stron-
ger GFP fluorescence than the control. This suggested
that gp41 had a single MSD that places the Kennedy
sequence, LLP-2, LLP-3, LLP-1 and the C-terminus of
gp41 in the cytoplasmic side. The analysis with b-lacta-
mase, another topology reporter, which is only active in
periplasm produced the data consistent with that of
GFP (data not shown). These data are consistent with
the results obtained by the currently available several
programs for prediction of transmembrane domains
(Table 3).
Our analysis of gp41 topology in mammalian cells
without membrane fusion (293FT cells) supported the
single transmembrane model, concordant with that of
Figure 6 Staining of 293FT cells cotransfected with the Env expression vector and pKcTac-Halo in the presence or absence of soluble
CD4 by membrane-impermeable ligand, Alexa Fluor 488 (AF488). Soluble CD4 (0.1 μM) was used to induce the conformational changes of
gp120. The names of the expression vectors used were shown on top. Merge: merged images of bright field and AF488 signals. The bar
indicates 40 μm.
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membrane impermeable ligands was observed for pHI-
Venv-gp41-5-Halo (truncation at position 747 in HXB2
Env) in fusion-competent 293CD4 cells. Since staining
for the preceding truncation point, pHIVenv-gp41-4-
Halo (truncation at the residue 725 in HXB2), was nega-
tive, suggesting an additional MSD between the residue
725 and 747. This region contains about 20 mainly
h y d r o p h i l i ca m i n oa c i dr e s i d u e st h a tc o r r e s p o n dt ot h e
Kennedy sequence. As shown in Table 3 no MSD was
predicted in this region by several computational algo-
rithms. So we speculated that there is other reason for
the observed apparently contradictory observations.
We examined the possibility of enhanced membrane
permeability to account for the staining of putative
intracellular regions during membrane fusion. The
intracellularly located HaloTag was labeled using the
membrane-impermeable ligand for HaloTag when HIV-
1 Env-mediated membrane fusion occurred (Figure 7).
Antibodies were also able to stain the intracellular tar-
gets in conditions of membrane fusion (Figure 8).
Although we cannot completely exclude the possible
alternations of the gp41 topology, the multiple MSD
model based on the epitope mapping [16,17] needs to
be reevaluated carefully given the increased permeability
we have observed.
We attempted to map the region(s) of gp41 responsible
for increased membrane permeability. Our data sug-
gested that the increased permeability was dependent on
active membrane fusion (Figure 7 and 8). It is consistent
with several reports of the fusion-dependent induction of
membrane permeability in HIV-1 infected cells [35-38].
Figure 7 Examination of the membrane permeability during membrane fusion. Staining of 293CD4 cells cotransfected with the Env
expression vector and pKcTac-Halo with membrane-impermeable ligand, Alexa Fluor 488 (AF488, shown in green) in the presence (+) or
absence (-) of the fusion inhibitor, C34 (2 μM). The names of the expression vectors used are shown in left. Staining and image capturing were
performed as described in Methods. For the HIV-1 Env with its native MSD images were captured at 16 h post transfection. The similar assay was
performed for CD22MSD mutants at 44 h post transfection. PI: images with propidium iodide staining as described in Methods. Merge: merged
images of bright field with AF488 and PI labelings. The bar indicates 40 μm.
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critical for membrane fusion, have potential to permeabi-
lize the mammalian and the bacterial membranes
[39-50]. These include the fusion peptide, the membrane
proximate external region, the MSD and the LLPs. Our
data of pHIVenv-gp41-5 (Figure 7 and 8) excludes the
possibility of the role of LLPs. Our data using MSD repla-
cement mutants pHIVenv-CD22-gp41-5 or pHIVenv-
CD22-gp41-8, suggested the MSD affected the level of
permeability, but whether the MSD directly affected the
permeability or the effect was mediated via the efficiency
of the membrane fusion was hard to be determined.
Since our assay relied on the topological reporter pro-
teins attached at the C-termini of truncated gp41 pro-
teins, the possibility of artifacts cannot be excluded. The
exact reason why neutralizing epitopes mapped to the
cytoplasmic regions remains unclear. There are at least
two possible explanations. First, it is possible that the
some of the antibodies themselves are intrinsically mem-
brane permeable. Second, permeability that is sufficient
to permit antibodies to cross the membrane may be
induced by membrane fusion. Although our findings sup-
port the latter model, further study is needed to explore
whether an alternative topology for gp41 MSD during
membrane fusion really takes place and if such a possibi-
lity is a general phenomenon for other HIV-1 strains.
Conclusions
The membrane topology of the gp41 subunit of HIV-1
Env was examined in both prokaryotic and mammalian
systems. The topology with a single MSD was supported
in both systems. In addition, augmented membrane
Figure 8 Examination of membrane permeability during membrane fusion using antibodies as probes. Staining of 293CD4 cells
cotransfected with the Env expression vector and pKcTac-FLAG in the presence (+) or absence (-) of C34 by anti-FLAG antibody. The pKcTac-
FLAG vector expresses the Tac proteins tagged with FLAG at their C-termini. Anti-FLAG: images after staining with the anti-FLAG antibody as
described in Methods are shown in green. The time points for the assay were same as Fig. 7 (16 h post transfection for wild type MSDs and 44
h for CD22MSDs, respectively). PI: Images after propidium iodide staining. Merge: merged images of Anti-FLAG and PI stainings together with
that of bright fields. The concentration of C34 was 2 μM. The names of the expression vectors used are shown in left. The bar indicates 40 μm.
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sequence of MSD and active membrane fusion.
List of abbreviations
Env: envelope glycoprotein; HIV-1: human immunodeficiency virus type-1;
LLP: lentiviral lytic peptide; MSD: membrane-spanning domain; GFP: green
fluorescent protein; GPI: glycosylphosphatidylinositol; FBS: fetal bovine
serum; OG: Oregon Green; AF488: Alexa Fluor 488; PI: propidium iodide; PBS:
phosphate buffered saline.
Acknowledgements
This work was supported by a contract research fund from the Ministry of
Education, Culture, Sports, Science and Technology for Program of Japan
Initiative for Global Research Network on Infectious Diseases. We thank Dr.
Kunito Yoshiike for his critical reading of the manuscript.
Additional material
Additional file 1: Supplemental Fig.1 Detection of HaloTag-attached
HIV-1 Env in 293FT cells. Images of the transfected 293FT cells stained
with membrane-permeable ligand, Oregon Green (OG). BF indicates the
bright filed images. The names of the expression vectors are shown.
Mock, mock DNA transfection.
Additional file 2: Supplemental Fig.2 Detection of HaloTag-attached
HIV-1 Env in 293CD4 cells. Images of the transfected 293CD4 cells
stained with membrane permeable ligand, Oregon Green (OG). The
nomenclature used are same as Supple Figure 1.
Additional file 3: Supplemental Fig.3 Expression of HIV-1 Env with
its native MSD or foreign CD22MSD in 293FT cells. The expression of
the envelope protein was examined by immunoblotting using the anti-
gp120 antibody as described previously [23]. The names of the
expression vectors were shown on top. The bands of gp160 and gp120
are indicated.
Author details
1China-Japan Joint Laboratory of Structural Virology and Immunology,
Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road,
Chaoyang District, Beijing 100101, P. R. China.
2Research Center for Asian
Infectious Diseases, and 3Division of Infectious Diseases, Advanced Clinical
Research Center, Institute of Medical Science, University of Tokyo, 4-6-1,
Shirokanedai Minato-ku, Tokyo 108-8639, Japan.
3Current Address:
Department of Pediatrics, Emory University School of Medicine, 2015
uppergate Dr. Atlanta, GA 30322, USA.
Authors’ contributions
SL, NK, YL and DX performed the experiments. The analysis in the
prokaryotic system was done by SL and DX. The work in mammalian system
was performed by SL, NK and YL. The study was conceived by ZM. AI
supervised the entire work. SL, NK and ZM wrote the manuscript. All authors
read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 13 July 2010 Accepted: 30 November 2010
Published: 30 November 2010
References
1. Dettenhofer M, Yu XF: Characterization of the biosynthesis of human
immunodeficiency virus type 1 Env from infected T-cells and the effects
of glucose trimming of Env on virion infectivity. J Biol Chem 2001,
276:5985-5991.
2. Otteken A, Earl PL, Moss B: Folding, assembly, and intracellular trafficking
of the human immunodeficiency virus type 1 envelope glycoprotein
analyzed with monoclonal antibodies recognizing maturational
intermediates. J Virol 1996, 70:3407-3415.
3. Dash B, McIntosh A, Barrett W, Daniels R: Deletion of a single N-linked
glycosylation site from the transmembrane envelope protein of human
immunodeficiency virus type 1 stops cleavage and transport of gp160
preventing env-mediated fusion. J Gen Virol 1994, 75(Pt 6):1389-1397.
4. Fenouillet E, Jones IM: The glycosylation of human immunodeficiency
virus type 1 transmembrane glycoprotein (gp41) is important for the
efficient intracellular transport of the envelope precursor gp160. J Gen
Virol 1995, 76(Pt 6):1509-1514.
5. Eisenberg D, Wesson M: The most highly amphiphilic alpha-helices
include two amino acid segments in human immunodeficiency virus
glycoprotein 41. Biopolymers 1990, 29:171-177.
6. Kliger Y, Shai Y: A leucine zipper-like sequence from the cytoplasmic tail
of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers.
Biochemistry 1997, 36:5157-5169.
7. Gawrisch K, Han KH, Yang JS, Bergelson LD, Ferretti JA: Interaction of
peptide fragment 828-848 of the envelope glycoprotein of human
immunodeficiency virus type I with lipid bilayers. Biochemistry 1993,
32:3112-3118.
8. Srinivas SK, Srinivas RV, Anantharamaiah GM, Segrest JP, Compans RW:
Membrane interactions of synthetic peptides corresponding to
amphipathic helical segments of the human immunodeficiency virus
type-1 envelope glycoprotein. J Biol Chem 1992, 267:7121-7127.
9. Viard M, Ablan SD, Zhou M, Veenstra TD, Freed EO, Raviv Y, Blumenthal R:
Photoinduced reactivity of the HIV-1 envelope glycoprotein with a
membrane-embedded probe reveals insertion of portions of the HIV-1
Gp41 cytoplasmic tail into the viral membrane. Biochemistry 2008,
47:1977-1983.
10. Muesing MA, Smith DH, Cabradilla CD, Benton CV, Lasky LA, Capon DJ:
Nucleic acid structure and expression of the human AIDS/
lymphadenopathy retrovirus. Nature 1985, 313:450-458.
11. Haffar OK, Dowbenko DJ, Berman PW: Topogenic analysis of the human
immunodeficiency virus type 1 envelope glycoprotein, gp160, in
microsomal membranes. J Cell Biol 1988, 107:1677-1687.
12. Yang C, Spies CP, Compans RW: The human and simian
immunodeficiency virus envelope glycoprotein transmembrane subunits
are palmitoylated. Proc Natl Acad Sci USA 1995, 92:9871-9875.
13. Rowell JF, Stanhope PE, Siliciano RF: Endocytosis of endogenously
synthesized HIV-1 envelope protein. Mechanism and role in processing
for association with class II MHC. J Immunol 1995, 155:473-488.
14. Kennedy RC, Henkel RD, Pauletti D, Allan JS, Lee TH, Essex M, Dreesman GR:
Antiserum to a synthetic peptide recognizes the HTLV-III envelope
glycoprotein. Science 1986, 231:1556-1559.
15. Vella C, Ferguson M, Dunn G, Meloen R, Langedijk H, Evans D, Minor PD:
Characterization and primary structure of a human immunodeficiency
virus type 1 (HIV-1) neutralization domain as presented by a poliovirus
type 1/HIV-1 chimera. J Gen Virol 1993, 74(Pt 12):2603-2607.
16. Cleveland SM, McLain L, Cheung L, Jones TD, Hollier M, Dimmock NJ: A
region of the C-terminal tail of the gp41 envelope glycoprotein of
human immunodeficiency virus type 1 contains a neutralizing epitope:
evidence for its exposure on the surface of the virion. J Gen Virol 2003,
84:591-602.
17. Lu L, Zhu Y, Huang J, Chen X, Yang H, Jiang S, Chen YH: Surface exposure
of the HIV-1 env cytoplasmic tail LLP2 domain during the membrane
fusion process: interaction with gp41 fusion core. J Biol Chem 2008,
283:16723-16731.
18. Yue L, Shang L, Hunter E: Truncation of the membrane-spanning domain
of human immunodeficiency virus type 1 envelope glycoprotein defines
elements required for fusion, incorporation, and infectivity. J Virol 2009,
83:11588-11598.
19. Shang L, Yue L, Hunter E: Role of the membrane-spanning domain of
human immunodeficiency virus type 1 envelope glycoprotein in cell-cell
fusion and virus infection. J Virol 2008, 82:5417-5428.
20. Salzwedel K, Johnston PB, Roberts SJ, Dubay JW, Hunter E: Expression and
characterization of glycophospholipid-anchored human
immunodeficiency virus type 1 envelope glycoproteins. J Virol 1993,
67:5279-5288.
21. Weiss CD, White JM: Characterization of stable Chinese hamster ovary
cells expressing wild-type, secreted, and glycosylphosphatidylinositol-
Liu et al. Retrovirology 2010, 7:100
http://www.retrovirology.com/content/7/1/100
Page 13 of 14anchored human immunodeficiency virus type 1 envelope glycoprotein.
J Virol 1993, 67:7060-7066.
22. Owens RJ, Burke C, Rose JK: Mutations in the membrane-spanning
domain of the human immunodeficiency virus envelope glycoprotein
that affect fusion activity. J Virol 1994, 68:570-574.
23. Miyauchi K, Komano J, Yokomaku Y, Sugiura W, Yamamoto N, Matsuda Z:
Role of the specific amino acid sequence of the membrane-spanning
domain of human immunodeficiency virus type 1 in membrane fusion. J
Virol 2005, 79:4720-4729.
24. Miyauchi K, Curran R, Matthews E, Komano J, Hoshino T, Engelman DM,
Matsuda Z: Mutations of conserved glycine residues within the
membrane-spanning domain of human immunodeficiency virus type 1
gp41 can inhibit membrane fusion and incorporation of Env onto
virions. Jpn J Infect Dis 2006, 59:77-84.
25. Wang J, Kondo N, Long Y, Iwamoto A, Matsuda Z: Monitoring of HIV-1
envelope-mediated membrane fusion using modified split green
fluorescent proteins. J Virol Methods 2009, 161:216-222.
26. Kondo N, Ebihara A, Ru H, Kuramitsu S, Iwamoto A, Rao Z, Matsuda Z:
Thermus thermophilus-derived protein tags that aid in preparation of
insoluble viral proteins. Anal Biochem 2009, 385:278-285.
27. Wilk T, Pfeiffer T, Bukovsky A, Moldenhauer G, Bosch V: Glycoprotein
incorporation and HIV-1 infectivity despite exchange of the gp160
membrane-spanning domain. Virology 1996, 218:269-274.
28. Caras IW, Weddell GN, Williams SR: Analysis of the signal for attachment
of a glycophospholipid membrane anchor. J Cell Biol 1989, 108:1387-1396.
29. Cosson P, Lankford SP, Bonifacino JS, Klausner RD: Membrane protein
association by potential intramembrane charge pairs. Nature 1991,
351:414-416.
30. van Genderen H, Kenis H, Lux P, Ungeth L, Maassen C, Deckers N, Narula J,
Hofstra L, Reutelingsperger C: In vitro measurement of cell death with the
annexin A5 affinity assay. Nat Protoc 2006, 1:363-367.
31. Drew D, Sjostrand D, Nilsson J, Urbig T, Chin CN, de Gier JW, von Heijne G:
Rapid topology mapping of Escherichia coli inner-membrane proteins
by prediction and PhoA/GFP fusion analysis. Proc Natl Acad Sci USA 2002,
99:2690-2695.
32. Duffy EB, Barquera B: Membrane topology mapping of the Na+-pumping
NADH: quinone oxidoreductase from Vibrio cholerae by PhoA-green
fluorescent protein fusion analysis. J Bacteriol 2006, 188:8343-8351.
33. Los GV, Encell LP, McDougall MG, Hartzell DD, Karassina N, Zimprich C,
Wood MG, Learish R, Ohana RF, Urh M, et al: HaloTag: a novel protein
labeling technology for cell imaging and protein analysis. ACS Chem Biol
2008, 3:373-382.
34. Kondo N, Miyauchi K, Meng F, Iwamoto A, Matsuda Z: Conformational
changes of the HIV-1 envelope protein during membrane fusion are
inhibited by the replacement of its membrane-spanning domain. J Biol
Chem 2010, 285:14681-14688.
35. Cloyd MW, Lynn WS: Perturbation of host-cell membrane is a primary
mechanism of HIV cytopathology. Virology 1991, 181:500-511.
36. Zhang H, Dornadula G, Alur P, Laughlin MA, Pomerantz RJ: Amphipathic
domains in the C terminus of the transmembrane protein (gp41)
permeabilize HIV-1 virions: a molecular mechanism underlying natural
endogenous reverse transcription. Proc Natl Acad Sci USA 1996,
93:12519-12524.
37. Gatti PJ, Choi B, Haislip AM, Fermin CD, Garry RF: Inhibition of HIV type 1
production by hygromycin B. AIDS Res Hum Retroviruses 1998, 14:885-892.
38. Voss TG, Fermin CD, Levy JA, Vigh S, Choi B, Garry RF: Alteration of
intracellular potassium and sodium concentrations correlates with
induction of cytopathic effects by human immunodeficiency virus. J Virol
1996, 70:5447-5454.
39. Miller MA, Cloyd MW, Liebmann J, Rinaldo CR, Islam KR, Wang SZ,
Mietzner TA, Montelaro RC: Alterations in cell membrane permeability by
the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein.
Virology 1993, 196:89-100.
40. Chernomordik L, Chanturiya AN, Suss-Toby E, Nora E, Zimmerberg J: An
amphipathic peptide from the C-terminal region of the human
immunodeficiency virus envelope glycoprotein causes pore formation in
membranes. J Virol 1994, 68:7115-7123.
41. Arroyo J, Boceta M, Gonzalez ME, Michel M, Carrasco L: Membrane
permeabilization by different regions of the human immunodeficiency
virus type 1 transmembrane glycoprotein gp41. J Virol 1995,
69:4095-4102.
42. Comardelle AM, Norris CH, Plymale DR, Gatti PJ, Choi B, Fermin CD,
Haislip AM, Tencza SB, Mietzner TA, Montelaro RC, Garry RF: A synthetic
peptide corresponding to the carboxy terminus of human
immunodeficiency virus type 1 transmembrane glycoprotein induces
alterations in the ionic permeability of Xenopus laevis oocytes. AIDS Res
Hum Retroviruses 1997, 13:1525-1532.
43. Suarez T, Gallaher WR, Agirre A, Goni FM, Nieva JL: Membrane interface-
interacting sequences within the ectodomain of the human
immunodeficiency virus type 1 envelope glycoprotein: putative role
during viral fusion. J Virol 2000, 74:8038-8047.
44. Suarez T, Nir S, Goni FM, Saez-Cirion A, Nieva JL: The pre-transmembrane
region of the human immunodeficiency virus type-1 glycoprotein: a
novel fusogenic sequence. FEBS Lett 2000, 477:145-149.
45. Brugger B, Glass B, Haberkant P, Leibrecht I, Wieland FT, Krausslich HG: The
HIV lipidome: a raft with an unusual composition. Proc Natl Acad Sci USA
2006, 103:2641-2646.
46. Saez-Cirion A, Arrondo JL, Gomara MJ, Lorizate M, Iloro I, Melikyan G,
Nieva JL: Structural and functional roles of HIV-1 gp41
pretransmembrane sequence segmentation. Biophys J 2003, 85:3769-3780.
47. Saez-Cirion A, Nir S, Lorizate M, Agirre A, Cruz A, Perez-Gil J, Nieva JL:
Sphingomyelin and cholesterol promote HIV-1 gp41 pretransmembrane
sequence surface aggregation and membrane restructuring. J Biol Chem
2002, 277:21776-21785.
48. Apellaniz B, Nir S, Nieva JL: Distinct mechanisms of lipid bilayer
perturbation induced by peptides derived from the membrane-proximal
external region of HIV-1 gp41. Biochemistry 2009, 48:5320-5331.
49. Huarte N, Lorizate M, Kunert R, Nieva JL: Lipid modulation of membrane-
bound epitope recognition and blocking by HIV-1 neutralizing
antibodies. FEBS Lett 2008, 582:3798-3804.
50. Dimitrov AS, Rawat SS, Jiang S, Blumenthal R: Role of the fusion peptide
and membrane-proximal domain in HIV-1 envelope glycoprotein-
mediated membrane fusion. Biochemistry 2003, 42:14150-14158.
doi:10.1186/1742-4690-7-100
Cite this article as: Liu et al.: Membrane topology analysis of HIV-1
envelope glycoprotein gp41. Retrovirology 2010 7:100.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Liu et al. Retrovirology 2010, 7:100
http://www.retrovirology.com/content/7/1/100
Page 14 of 14